⌘K
Loading ticker…
As of 2026-08-24, Treace Medical Concepts, Inc. Common Stock (TMCI) has a 3-month relative strength percentile of 95 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 65. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 7.6%, relative volume 0.80×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
TMCI is held by 11 ETFs as of May 2026. Top owner: VTWO at 0.00% weight, $863K notional. Top 3 carry $2M.
Held by 20 ETFs · $7M across latest filings · largest weight 0.01% (VTWG).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTWO | 0.00% | $863K | — |
| SCHASchwab U.S. Small-Cap ETF | 0.00% | $795K | — |
| VHTVanguard Health Care ETF | 0.00% | $521K | — |
| VTWG | 0.01% | $157K | — |
| VTHRVanguard Russell 3000 ETF | 0.00% | $10K | — |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| ITWO | 0.00% | $8K | — |
| URTY | 0.00% | $6K | — |
| UWM | 0.00% | $6K | — |
| MSSM | 0.00% | $6K | — |
| HDG | 0.00% | $156 | — |
Showing 10 of 11 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TMCI Jan avg: 8.98% median: 3.08% win: 75% σ: 17.97% n: 4 2022-04-12 → 2026-07-31 | TMCI Feb avg: -9.56% median: -9.05% win: 0% σ: 8.16% n: 4 2022-04-12 → 2026-07-31 | TMCI Mar avg: -4.91% median: -4.53% win: 25% σ: 18.56% n: 4 2022-04-12 → 2026-07-31 | TMCI Apr avg: 0.04% median: -2.78% win: 40% σ: 21.91% n: 5 2022-04-12 → 2026-07-31 | TMCI May avg: 4.54% median: -14.85% win: 40% σ: 51.80% n: 5 2022-04-12 → 2026-07-31 | TMCI Jun avg: 2.53% median: 2.44% win: 60% σ: 12.09% n: 5 2022-04-12 → 2026-07-31 | TMCI Jul avg: 3.08% median: 8.29% win: 60% σ: 12.40% n: 5 2022-04-12 → 2026-07-31 | TMCI Aug avg: 2.16% median: 1.86% win: 50% σ: 31.03% n: 4 2022-04-12 → 2026-07-31 (current) | TMCI Sep avg: -5.02% median: -7.29% win: 25% σ: 10.94% n: 4 2022-04-12 → 2026-07-31 | TMCI Oct avg: -9.25% median: -12.21% win: 25% σ: 15.68% n: 4 2022-04-12 → 2026-07-31 | TMCI Nov avg: 2.84% median: -9.05% win: 25% σ: 57.35% n: 4 2022-04-12 → 2026-07-31 | TMCI Dec avg: 3.60% median: -6.68% win: 25% σ: 28.87% n: 4 2022-04-12 → 2026-07-31 |